Few Short-Term Differences Seen Between Lucentis And Avastin In Treating Choroidal Neovascularisation: Presented At ARVO

DG News

There appear to be few meaningful differences other than price between the vascular endothelial growth factor inhibitors ranibizumab and bevacizumab -- at least in the short term.
  • <<
  • >>

Comments